Tandem Diabetes Correlations
TNDM Stock | USD 33.47 0.86 2.64% |
The current 90-days correlation between Tandem Diabetes Care and Inspire Medical Systems is 0.19 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tandem Diabetes moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tandem Diabetes Care moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Tandem Diabetes Correlation With Market
Average diversification
The correlation between Tandem Diabetes Care and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tandem Diabetes Care and DJI in the same portfolio, assuming nothing else is changed.
Tandem |
Moving together with Tandem Stock
0.61 | IRMD | Iradimed | PairCorr |
0.71 | NPCE | Neuropace | PairCorr |
0.77 | ANGO | AngioDynamics | PairCorr |
0.77 | DRTS | Alpha Tau Medical | PairCorr |
0.64 | XFOR | X4 Pharmaceuticals | PairCorr |
0.71 | PFE | Pfizer Inc | PairCorr |
Moving against Tandem Stock
0.88 | FHTX | Foghorn Therapeutics Trending | PairCorr |
0.84 | PAVM | PAVmed Inc | PairCorr |
0.77 | FDMT | 4D Molecular Therapeutics | PairCorr |
0.74 | CGC | Canopy Growth Corp | PairCorr |
0.72 | LIVN | LivaNova PLC Earnings Call This Week | PairCorr |
0.69 | EWTX | Edgewise Therapeutics Earnings Call This Week | PairCorr |
0.65 | COO | Cooper Companies, Downward Rally | PairCorr |
0.65 | TFX | Teleflex Incorporated Earnings Call This Week | PairCorr |
0.51 | OFIX | Orthofix Medical | PairCorr |
0.51 | ERAS | Erasca Inc | PairCorr |
0.48 | CRVL | CorVel Corp | PairCorr |
0.43 | CVS | CVS Health Corp Aggressive Push | PairCorr |
0.33 | ICUI | ICU Medical | PairCorr |
0.32 | SRDX | SurModics | PairCorr |
0.83 | LYEL | Lyell Immunopharma | PairCorr |
0.77 | LRMR | Larimar Therapeutics | PairCorr |
0.73 | HOOK | Hookipa Pharma | PairCorr |
0.71 | KRYS | Krystal Biotech Earnings Call This Week | PairCorr |
0.7 | MRSN | Mersana Therapeutics | PairCorr |
0.68 | GLUE | Monte Rosa Therapeutics | PairCorr |
0.68 | INVA | Innoviva | PairCorr |
0.67 | GBIO | Generation Bio | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Tandem Stock performing well and Tandem Diabetes Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tandem Diabetes' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
DXCM | 1.61 | 0.38 | 0.21 | 0.80 | 1.48 | 5.57 | 10.13 | |||
INSP | 2.26 | (0.05) | 0.00 | (0.06) | 0.00 | 4.95 | 18.97 | |||
SWAV | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
PEN | 1.33 | 0.20 | 0.14 | 0.41 | 1.24 | 2.85 | 9.09 | |||
PODD | 1.05 | 0.07 | 0.06 | 0.20 | 1.08 | 3.21 | 6.27 | |||
ABT | 0.88 | 0.18 | 0.17 | 0.31 | 0.85 | 2.53 | 7.53 | |||
ALGN | 1.65 | (0.08) | 0.00 | (0.13) | 0.00 | 2.86 | 13.52 | |||
SYK | 0.94 | 0.04 | 0.03 | 0.08 | 1.02 | 2.18 | 5.32 | |||
ASXC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tandem Diabetes Corporate Management
Tom Fox | Chief Officer | Profile | |
Susan Morrison | Chief Admin. Officer | Profile | |
Mark Novara | Executive Officer | Profile | |
Ross Sylvia | VP Marketing | Profile | |
David Esq | Transitional Advisor | Profile | |
Jordan MD | Chief Officer | Profile |